共有 39 笔近期内部人交易记录记录，涉及 aTyr Pharma, Inc. (ATYR), 包括 22 笔买入 和 16 笔卖出. 内部人买入总额为 $10.05M 内部人卖出总额为 $2.74M.
近期活跃的重要内部人包括 Broadfoot Jill Marie, Denyes Nancy, Shukla Sanjay. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ATYR
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-02-04 |
Broadfoot Jill Marie |
Chief Financial Officer |
知情卖出 |
1,558 |
$0.98 |
$1.52K |
37,296 |
| 2026-02-04 |
Denyes Nancy |
General Counsel |
知情卖出 |
1,118 |
$0.98 |
$1.09K |
33,124 |
| 2026-02-04 |
Shukla Sanjay |
President and CEO |
知情卖出 |
3,745 |
$0.98 |
$3.66K |
153,553 |
| 2026-02-03 |
Broadfoot Jill Marie |
Chief Financial Officer |
期权行权（卖出） |
3,750 |
- |
- |
- |
| 2026-02-03 |
Denyes Nancy |
General Counsel |
期权行权（卖出） |
2,687 |
- |
- |
- |
| 2026-02-03 |
Shukla Sanjay |
President and CEO |
期权行权（卖出） |
10,375 |
- |
- |
- |
| 2026-01-09 |
Broadfoot Jill Marie |
Chief Financial Officer |
限制性股票授予 (RSU) |
412,500 |
$0.71 |
$293.99K |
412,500 |
| 2026-01-09 |
Denyes Nancy |
General Counsel |
限制性股票授予 (RSU) |
412,500 |
$0.71 |
$293.99K |
412,500 |
| 2026-01-09 |
Shukla Sanjay |
President and CEO |
限制性股票授予 (RSU) |
1,500,000 |
$0.71 |
$1.07M |
1,500,000 |
| 2025-10-09 |
Schimmel Paul |
Director |
知情买入 |
317,999 |
$0.94 |
$299.36K |
1,413,023 |
| 2025-10-08 |
Schimmel Paul |
Director |
知情买入 |
682,001 |
$0.90 |
$612.44K |
1,095,024 |
| 2025-05-01 |
Schimmel Paul |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-05-01 |
Coughlin Timothy |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-05-01 |
Zaknoen Sara |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-05-01 |
Benevich Eric |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-05-01 |
Gross Jane A |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-05-01 |
Lucas Svetlana |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.34 |
$167K |
50,000 |
| 2025-03-17 |
Gross Jane A |
Director |
知情买入 |
3,750 |
$4.00 |
$15K |
9,750 |
| 2025-02-04 |
Broadfoot Jill Marie |
Chief Financial Officer |
知情卖出 |
1,254 |
$3.78 |
$4.74K |
31,763 |
| 2025-02-04 |
Denyes Nancy |
General Counsel |
知情卖出 |
899 |
$3.78 |
$3.4K |
26,555 |
| 2025-02-03 |
Broadfoot Jill Marie |
Chief Financial Officer |
期权行权（卖出） |
3,750 |
- |
- |
3,750 |
| 2025-02-03 |
Denyes Nancy |
General Counsel |
期权行权（卖出） |
2,687 |
- |
- |
2,687 |
| 2025-02-03 |
Shukla Sanjay |
President and CEO |
期权行权（卖出） |
10,375 |
- |
- |
10,375 |
| 2025-01-08 |
Broadfoot Jill Marie |
Chief Financial Officer |
限制性股票授予 (RSU) |
275,000 |
$3.74 |
$1.03M |
275,000 |
| 2025-01-08 |
Denyes Nancy |
General Counsel |
限制性股票授予 (RSU) |
275,000 |
$3.74 |
$1.03M |
275,000 |
| 2025-01-08 |
Shukla Sanjay |
President and CEO |
限制性股票授予 (RSU) |
1,000,000 |
$3.74 |
$3.74M |
1,000,000 |
| 2024-12-10 |
Benevich Eric |
Officer |
未知 |
- |
- |
- |
- |
| 2024-12-10 |
Benevich Eric |
Director |
限制性股票授予 (RSU) |
100,000 |
$3.29 |
$329K |
100,000 |
| 2024-07-24 |
Schimmel Paul |
Director |
知情买入 |
52,300 |
$1.93 |
$101.04K |
413,023 |
| 2024-07-23 |
Schimmel Paul |
Director |
知情买入 |
6,648 |
$1.82 |
$12.07K |
360,723 |
| 2024-07-22 |
Schimmel Paul |
Director |
知情买入 |
41,052 |
$1.74 |
$71.5K |
354,075 |
| 2024-06-05 |
Denyes Nancy |
General Counsel |
知情买入 |
5,000 |
$1.86 |
$9.28K |
22,267 |
| 2017-11-13 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情卖出 |
1,083 |
$3.95 |
$4.28K |
3,209,316 |
| 2017-11-10 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情卖出 |
5,860 |
$4.00 |
$23.44K |
3,210,399 |
| 2017-11-09 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情卖出 |
5,819 |
$4.15 |
$24.15K |
3,216,259 |
| 2017-11-08 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情卖出 |
1,070 |
$4.30 |
$4.6K |
3,222,078 |
| 2017-11-01 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情买入 |
24,728 |
$4.80 |
$118.69K |
3,223,148 |
| 2017-10-01 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
知情买入 |
4,879 |
$5.05 |
$24.64K |
3,198,420 |
| 2017-08-28 |
Ecor1 Capital Fund Qualified, L.p. |
10 Percent Owner |
处置 |
574,245 |
$4.64 |
$2.66M |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
